
Price:
Price 16500.0 INR / Piece
Minimum Order Quantity : 1 Piece
Drug Type : Injection
Physical Form : Liquid
Ingredients : Denosurel 120mg Injection contains Denosumab, a targeted medication used to strengthen bones and prevent bonerelated complications in patients with osteoporosis, multiple myeloma, and cancers that have spread to the bones (bone metastases). It works by blocking RANK ligand, a protein involved in bone breakdown, helping to reduce bone loss, increase bone density, and lower the risk of fractures. Clinical studies have shown that Denosumab can significantly improve bone strength in postmenopausal women with osteoporosis and individuals experiencing cancerrelated bone loss. Patients receiving Denosurel 120mg Injection should ensure adequate calcium and vitamin D intake throughout treatment to support healthy bone metabolism and reduce the risk of low calcium levels. Individuals with moderate kidney impairment may require regular monitoring of renal function during therapy. This medication should not be used by patients with a known allergy to Denosumab or any of its ingredients and should be administered with caution in those with preexisting hypoparathyroidism. As the safety and effectiveness of Denosurel 120mg Injection have not been established in children and adolescents, it is not recommended for individuals under 18 years of age. When used under medical supervision, Denosurel 120mg Injection can play an important role in protecting bone health and preventing serious skeletal complications.
Dosage Form : Injection
Price 6500.0 INR / Unit
Minimum Order Quantity : 10 Packs
Drug Type : Injection
Physical Form : Liquid
Ingredients : Olimab 60mg Injection contains Denosumab, a monoclonal antibody used to treat osteoporosis and other conditions associated with bone loss. It is commonly prescribed for postmenopausal women and men at high risk of fractures, helping to strengthen bones and reduce the likelihood of broken bones. Olimab 60mg Injection is also used to prevent bonerelated complications in patients with certain cancers, including multiple myeloma and cancers that have spread to the bones. It works by blocking RANK ligand, a protein responsible for bone breakdown, thereby increasing bone density and improving bone strength. Adequate calcium and vitamin D supplementation is essential during treatment to support bone health and reduce the risk of low calcium levels. Patients with moderate kidney impairment may require close monitoring of renal function while receiving this medication. Olimab 60mg Injection should not be used by individuals with a known allergy to Denosumab or any of its ingredients and should be used cautiously in patients with preexisting hypoparathyroidism. As its safety and effectiveness have not been established in children and adolescents, this medication is not recommended for individuals under 18 years of age. When used as prescribed, Olimab 60mg Injection can play an important role in managing osteoporosis and protecting against bonerelated complications.
Dosage Form : Liquid
Price 4850.0 INR / Millimeter
Minimum Order Quantity : 5 Pieces
Drug Type : Injection
Physical Form : Liquid
Ingredients : Teriparatide Injection is a boneforming medication used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures or who have not responded adequately to other osteoporosis treatments. It works by stimulating new bone growth, increasing bone mineral density, and strengthening bones to reduce the risk of fractures. Available in injection, cartridge, and pen formulations, Teriparatide is administered as a oncedaily subcutaneous injection into the thigh or abdominal area, with or without food, as directed by a healthcare professional. Common side effects may include joint pain, headache, nausea, dizziness, neck pain, constipation, diarrhea, indigestion, vomiting, hypertension, rash, sweating, cough, insomnia, depression, and vertigo. Patients should seek medical attention if they experience injectionsite reactions such as swelling, bruising, itching, or severe allergic symptoms. Teriparatide is not recommended for individuals with an increased risk of bone cancer, including those with Paget s disease, hereditary bone disorders, skeletal malignancies, hypercalcemia, urolithiasis (kidney stones), or orthostatic hypotension. Before starting treatment, patients should inform their doctor about any history of heart disease, bone disorders, kidney problems, or other significant medical conditions. Regular monitoring of blood calcium levels, urine calcium levels, and kidney function may be required during therapy to help ensure safe and effective treatment outcomes.
Dosage Form : Injection
Price 8000.0 INR / Box
Minimum Order Quantity : 1 Piece
Drug Type : General Medicines
Physical Form : Liquid
Ingredients : Exemptia 40mg Injection contains Adalimumab, a biologic diseasemodifying antirheumatic drug (DMARD) that belongs to the tumor necrosis factor (TNF) inhibitor class. It is used to treat a variety of autoimmune and inflammatory conditions by reducing inflammation and controlling the overactive immune response that causes tissue damage. Exemptia 40mg Injection is prescribed for conditions such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitisrelated arthritis, ankylosing spondylitis, nonradiographic axial spondyloarthritis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn s disease, ulcerative colitis, and noninfectious uveitis. By blocking TNF, a key inflammatory protein in the body, this medication helps relieve symptoms such as joint pain, swelling, stiffness, skin lesions, and intestinal inflammation while improving overall quality of life. Exemptia 40mg Injection should not be used in patients who are allergic to Adalimumab, have active tuberculosis, severe infections, or moderate to severe heart failure. Before starting treatment, patients should inform their healthcare provider about any current infections, lung conditions, heart disease, liver or kidney disorders, and all medications they are taking. Women who are pregnant, planning a pregnancy, or breastfeeding should consult their doctor before using this medication. Regular medical monitoring may be recommended during treatment to ensure safety and maximize therapeutic benefits.
Dosage Form : injection